BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for September 2019
NW Florida fundraiser marks 6th year with its most donations ever Six years ago, Jennifer (Gin) Newman’s father, Simon Mckee, was diagnosed with metastatic prostate cancer with a PSA of...Read More
1 in 9 men will be diagnosed with prostate cancer, but did you know that prostate cancer is 99% treatable if detected early? September, National Prostate Cancer Awareness Month, is...Read More